Viewing Study NCT02776735


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2026-01-05 @ 12:02 AM
Study NCT ID: NCT02776735
Status: COMPLETED
Last Update Posted: 2024-10-15
First Post: 2016-05-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-09-06
Start Date Type: ACTUAL
Primary Completion Date: 2022-04-08
Primary Completion Date Type: ACTUAL
Completion Date: 2023-12-27
Completion Date Type: ACTUAL
First Submit Date: 2016-05-16
First Submit QC Date: None
Study First Post Date: 2016-05-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-07-03
Results First Submit QC Date: None
Results First Post Date: 2024-10-15
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2023-04-11
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-10-07
Last Update Post Date: 2024-10-15
Last Update Post Date Type: ACTUAL